Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
Historique:
received: 11 09 2020
accepted: 28 10 2020
pubmed: 1 12 2020
medline: 15 12 2020
entrez: 30 11 2020
Statut: ppublish

Résumé

Despite availability of efficacious treatments, unmet needs still exist, preventing optimal and comprehensive management of rheumatoid arthritis (RA). Evolving the management of RA (eRA) is a European-wide educational initiative aiming to support improved patient care through practical and educational tools addressing specific unmet needs. A multidisciplinary Steering Committee (17 members, 12 countries) identified unmet needs within the management of RA and prioritised those with the greatest impact on patient outcomes. Practical educational tools addressing priority needs were then developed for dissemination and implementation by the rheumatology community across Europe. Five areas of priority need were identified: increasing early recognition of RA and treatment initiation; treating RA to target; optimal, holistic approach to selection of treatment strategy, including shared decision-making; improving identification and management of comorbidities; and non-pharmacological patient management. A suite of 14 eRA tools included educational slides, best-practice guidance, self‑assessment questionnaires, clinical checklists, a multidisciplinary team training exercise, an interactive patient infographic, and case scenarios. By April 2020, rheumatology professionals in 17 countries had been actively engaged in the eRA programme; in 11 countries, eRA tools were selected by national leaders in rheumatology and translated for local dissemination. A web platform, with country-specific pages, was developed to support access to the translated tools (https://www.evolvingthemanagementofra.com/). The eRA programme supports comprehensive management of RA across Europe through development and dissemination of practical educational tools. The eRA tools address priority needs and are available free of charge to the rheumatology community.

Identifiants

pubmed: 33253107
pii: 16439

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1056-1067

Auteurs

Gerd-Rüdiger Burmester (GR)

Department of Rheumatology and Clinical Immunology, Charité - University Medicine Berlin, Free University and Humboldt University Berlin, Germany. gerd.burmester@charite.de.

José María Álvaro-Gracia (JM)

Rheumatology Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense de Madrid, Spain.

Neil Betteridge (N)

Neil Betteridge Associates, London, UK.

Jaime Calvo Alén (J)

Jefe de Servicio de Reumatología del Hospital Universitario Araba, Vitoria-Gasteiz, Álava, Spain.

Bernard Combe (B)

Departement de Rhumatologie, CHU Montpellier, Université Montpellier, France.

Patrick Durez (P)

Rheumatology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium.

Bruno Fautrel (B)

Rheumatology, Pitié-Salpêtrière University Hospital, Sorbonne Université/Assistance Publique, Hôpitaux de Paris, France.

Ricardo J O Ferreira (RJO)

Serviço de Reumatologia, Centro Hospitalar e Universitário de Coimbra, Portugal.

Cem Gabay (C)

Department of Medicine and Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Switzerland.

Annamaria Iagnocco (A)

Academic Rheumatology Centre, Università degli Studi di Torino, Italy.

Carlomaurizio Montecucco (C)

Department of Rheumatology, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.

Mikkel Østergaard (M)

Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, and Department of Clinical Medicine, University of Copenhagen, Denmark.

Sofia Ramiro (S)

Leiden University Medical Center, Leiden, and Zuyderland Medical Center, Heerlen, The Netherlands.

Andrea Rubbert-Roth (A)

Klinik für Rheumatologie, Kantonsspital St.Gallen, Switzerland.

Tanja Stamm (T)

Section for Outcomes Research, Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Austria.

Zoltán Szekanecz (Z)

Division of Rheumatology, Faculty of Medicine, University of Debrecen, Hungary.

Peter C Taylor (PC)

Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK.

Mart van de Laar (M)

University of Twente, Faculty of Behavioural, Management and Social Sciences, Enschede, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH